Old Web
English
Sign In
Acemap
>
authorDetail
>
Ruben A. Mesa
Ruben A. Mesa
University of Texas MD Anderson Cancer Center
Myelofibrosis
Medicine
Immunology
Internal medicine
Hepcidin
3
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Hepcidin Suppression By Momelotinib Is Associated with Increased Iron Availability and Erythropoiesis in Transfusion-Dependent Myelofibrosis Patients
2018
Blood
Stephen T. Oh
Moshe Talpaz
Aaron T. Gerds
Vikas Gupta
Srdan Verstovsek
Ruben A. Mesa
Carole B. Miller
Candido E. Rivera
Angela G. Fleischman
Swati Goel
Mark L. Heaney
Casey O’Connell
Murat O. Arcasoy
Yafeng Zhang
Jun Kawashima
Tomas Ganz
Carrie Baker Brachmann
Show All
Source
Cite
Save
Citations (4)
Pooled Analyses of Total Symptom Score (TSS) Responses in Patients with Myelofibrosis (MF) Treated with Pacritinib (PAC) Vs Best Available Therapy (BAT) in Phase 3 Studies (PERSIST-1, PERSIST-2)
2018
Blood
Ruben A. Mesa
Francisco Cervantes
Claire N. Harrison
Adam J. Mead
Alessandro M. Vannucchi
Srdan Verstovsek
Lixia Wang
Tanya Granston
John Mascarenhas
Show All
Source
Cite
Save
Citations (0)
Real-World Risk Assessment and Treatment of Patients with Myelofibrosis at Community Oncology Practices in the United States
2018
Blood
Srdan Verstovsek
Jingbo Yu
Jonathan K. Kish
Dilan Paranagama
Jill Kaufman
Jessica Chung
Michael R. Grunwald
Philomena Colucci
Ruben A. Mesa
Show All
Source
Cite
Save
Citations (0)
1